I

f at first you don’t succeed …

After being rebuffed by the Obama administration, a consumer advocacy group is now asking the Trump administration to use federal law to widen access in the United States to a pricey prostate cancer drug that was developed with taxpayer funds.

This is a STAT Plus article and is only available to STAT Plus subscribers.
To read the full story, subscribe to STAT Plus or log in to your account.
Good news: your first 30 days are on us.

Leave a Comment

Please enter your name.
Please enter a comment.

Recommended Stories

Sign up for our biotech newsletter, The Readout

A guide to what’s new in biotech — delivered straight to your inbox every weekday morning.